Advances in the infused cannabis products and extracts area have nearly tripled in 2019, making it one of the fastest-growing spaces for raising capital.
MJBizDaily reported that the sector raised nearly $390.29 million through the second week of June, attributing a majority ($322.28 million) in equity deals.
As cannabis legalization is spreading like wildfire, there is one cutting-edge company that we are watching closely: Chineseinvestors.com, Inc. (“CIIX”).
CIIX owns and operates www.ChineseCBDoil.com, one of the world’s first online stores in the Chinese Language offering industrial hemp-derived CBD products. The website provides a variety of supplements containing hemp-derived CBD, including soft gels, capsules and concentrates, for Chinese-speaking customers worldwide.
Provided that the Chinese American population nears 3.8 million, CIIX has also opened its retail store in the predominantly Chinese community of San Gabriel, California, also where the Company’s headquarters are located.
Today we’re highlighting: Chineseinvestors.com, Inc. (OTCQB: CIIX), Heineken N.V. (OTCQX: HEINY), Constellation Brands, Inc. (NYSE: STZ), Terra Tech Corp. (OTCQX: TRTC), GW Pharmaceuticals plc (NASDAQ: GWPH).
Chineseinvestors.com, Inc. (OTCQB: CIIX), (Market Cap: $19.238M; Share Price: $0.4265), Chineseinvestors.com, Inc. provides Web-based real-time financial information in Chinese language for the Chinese population in the United States and internationally. The company offers various subscription services, including real-time market commentary and analysis in the Chinese language. The company also provides advisory services on the U.S. capital markets, the U.S. legal system, and the U.S. Securities markets; Website-based advertising services; price chart and news updated on stocks, Website research tools; and additional education services, such as courses offering basic knowledge and practical trading skills. In addition, it offers Website content comprising stock quotes, trading volumes, and pricing indicators for listed companies in the United States. Further, the company sells hemp oil, soft gels, and gummies through its Website, ChineseHempOil.com and Chinese Wellness Center. It provides in person and online courses on crypto currency investment and trading. The company offers its services through its Websites, as well as through customer support personnel at its telemarketing and customer service center.
Heineken N.V. (OTCQX: HEINY), (Market Cap: $63.731B; Share Price: $56.40), On June 26,
2018, Lagunitas, a subsidiary of Heineken, announced that it will launch an IPA-inspired
sparkling water which contains hops and is infused with THC and/or CBD. Hi-FI HOPS, the
name of Lagunitas; cannabis infused beverage, was successfully launched on July 30th, 2018.
Lagunitas partnered with AbsoluteXtracts, a manufacturer of cannabis-based products, to make
the drink. HI-FI HOPS contains 10mg of THC and zero calories but is also available in a version
that contains only 5mg of THC and 5mg of CBD.
Constellation Brands, Inc. (NYSE: STZ), (Market Cap: $34.941B; Share Price: $183.48), Constellation Brands, Inc., together with its subsidiaries, produces, imports, and markets beer, wine, and spirits in the United States, Canada, Mexico, New Zealand, and Italy. It provides beer primarily under the Corona Extra, Corona Light, Corona Premier, Corona Familiar Modelo Especial, Modelo Negra, Modelo Chelada, Pacifico, and Victoria brands, as well as Funky Buddha, Four Corners, and Ballast Point brands. Constellation Brands, Inc. is reportedly planning to sell drinks that contain marijuana in conjunction with their stake in Canopy Growth.
Terra Tech Corp. (OTCQX: TRTC), (Market Cap: $61.003M; Share Price: $0.5999), Terra Tech Corp. operates through multiple subsidiary businesses including: Blum, IVXX Inc., MediFarm LLC and Edible Garden. Blum’s retail medical and adult use cannabis facilities focus on providing the highest quality cannabis to its customers. Blum offers a broad selection of medical and adult use cannabis products including; flowers, concentrates and edibles through its Oakland and Santa Ana, CA and multiple Nevada locations. IVXX, Inc. is a wholly-owned subsidiary of Terra Tech that produces medical and adult use cannabis-extracted products for regulated medical cannabis dispensaries throughout California. Terra Tech’s MediFarm LLC subsidiaries are focused on cannabis cultivation and permitting businesses throughout Nevada.
GW Pharmaceuticals plc (NASDAQ: GWPH), (Market Cap: $5.282B; Share Price: $171.97), GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. Its lead product is Epidiolex, an oral medicine for the treatment of refractory childhood epilepsies, as well as for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, and infantile spasms. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis.
As the demand for cannabis continues to grow, CIIX is a company worth watching as they cater to a highly dense demographic which will undoubtedly build brand loyalty and repeat customers for years to come.
This article was written by Regal Consulting, LLC (“Regal Consulting”). Regal Consulting has agreed to a six month term consulting agreement with CIIX dated 6/20/2019. The agreement calls for $20,000 in cash, and 30,000 restricted 144 shares of CIIX per month. All payments were made directly by ChineseInvestors.com, Inc. to provide investor relations services, of which this article is a part of. Regal Consulting also paid one thousand dollars cash to microcapspeculators.com to distribute this article. Regal Consulting has a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice. This article is based on public information and the opinions of Regal Consulting. CIIX was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein. Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice.
Company Name: Microcap Speculators
Contact Person: Media Manager
Country: United States